¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦

ÀÎõ°©»ó¼±ÇÑÀÇ¿ø ÇÑÀÇ¿ø ¼­µÎ¸£¼¼¿ä

ÃßõÇϱâ
ÇÑÀÇ¿ø À̹øÁÖ BEST
 
#¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø, #¼Ûµµ°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø, #°©»ó¼º±â´ÉÀúÇÏÁõ, #¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ, #°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø, #°©»ó¼º±â´ÉÀúÇÏÁõÇÑÀÇ¿ø, #¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ, #ºÎõ°©»ó¼±ÇÑÀÇ¿ø ¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø,,¼Ûµµ°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø,,°©»ó¼º±â´ÉÀúÇÏÁõ,,¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ,,°©»ó¼±ÇÑÀÇ¿øÇÑÀÇ¿ø,,°©»ó¼º±â´ÉÀúÇÏÁõÇÑÀÇ¿ø,,¼Ûµµ°©»ó¼º±â´ÉÀúÇÏÁõ,,ºÎõ°©»ó¼±ÇÑÀÇ¿ø ¾È³çÇϼ¼¿ä. ¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø ºÎõ ÇÑÀÇ¿ø ãÀ¸½Ã´Â ºÐµéÀÌ ¸¹À¸½Åµ¥¿ä ¼Ûµµ°©»ó¼±ÇÑÀÇ¿ø ºÎõ Ä¡·á ãÀ¸½Ã´Â ºÐµéÀÌ ¹Ì¿ÃÇÑÀÇ¿ø ¼ÛµµÁ¡À» ÀÚÁÖ Ã£À¸½Ã´Âµ¥¿ä. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â°©»ó¼º±â´ÉÀúÇÏÁõ, °©»ó¼±ÇÑÀÇ¿ø, °©»ó¼±È¤, °©»ó¼±Áõ»ó, °©»ó¼±¿ä¿Àµå, °©»ó¼±±â´ÉÇ×ÁøÁõ, °©»ó¼±Å¬¸®´Ð, °©»ó¼±Ä¡·á, °©»ó¼±±â´ÉÀúÇÏÁõÇÑÀÇ¿ø, °©»ó¼±, °©»ó¼±Ç×ÁøÁõ, °©»ó¼±µÎÅë, ¸ñ°©»ó¼±, °©»ó¼±¿ä¿Àµå, °©»ó¼º±â´ÉÀúÇÏÁõ, °©»ó¼±Ã¼ÁßÁõ°¡, °©»ó¼±±â´ÉÀúÇÏÁõÀÓ½Å, °©»ó¼±ºÎÀ½, °©»ó¼±±â´ÉÀúÇÏÁõÀÓ½Å, °©»ó¼±±â´ÉÇ×ÁøÁõÇÑÀÇ¿ø, °©»ó¼±Ä¡·á, °©»ó»ùÀúÇÏÁõ, °©»ó¼±°áÀý, °©»ó¼±È¤Áõ»ó, °©»ó¼±Ã¼ÁßÁõ°¡µî ´Ù¾çÇÑ ¹®ÀǸ¦ ÁÖ°í °è½Ê´Ï´Ù. ¹Ì¿ÃÇÑÀÇ¿ø¿¡´Â ´Ù¾çÇÑ È¯ÀںеéÀÌ ³»¿øÇÏ°í °è½Ã¸ç °³Àκ° Áõ»ó°ú üÁú¿¡ µû¶ó Àδ밭ȭ, üÁßÁ¶Àý¿µ¾ç±³À°ÆÐÅ°Áö, ôÃß±â±âµµÀÎ, ¸¶»çÁö, °üÀýôÃߺÀ¾àħ¿ä¹ý, ¾Æ·Î¸¶Å׶óÇÇ, ÃÊÀ½ÆĽɺο­Ä¡·á, ±Ý¿¬Ä§, ÇѹæÀçÈ°, ÀåħÀü±âÀڱؼú, °ñµµ¹ý°Ë»ç, °üÀýº¸È£´ë, ºñ°­·¹ÀÌÀú, °æÇÇÀû¿Ü¼±Á¶»ç¿ä¹ý, sonostim, ÀÚÇϰžàħ, Ư¼öÃß³ª, ¾óÀ½ÆÑ, µµÀοä¹ý, ¼ÒÇÕÇâ¿ø, ¸ÂÃãÇÑ¾à µî ÇÕ¸®ÀûÀÌ°í È¿°úÀûÀÎ ¸ÂÃã Ä¡·á¸¦ Á¦°øÇÏ°í ÀÖ½À´Ï´Ù ¹Ì¿ÃÇÑÀÇ¿øÀº Àü±¹ 20¿©°³ ÁöÁ¡¿¡¼­ Áø·áÁßÀÌ¸ç °æ³² °í¼º±º ¿µÇö¸é, °æ±â ¼º³²½Ã Áß¿ø±¸ ÇÏ´ë¿øµ¿, °æ³² â¿ø½Ã ¸¶»êÇÕÆ÷±¸ ´ë¿Üµ¿, °æºÏ ±èõ½Ã ÀÀ¸íµ¿, Ãæ³² È«¼º±º Àå°î¸é, °æ±â µ¿µÎõ½Ã ±¤¾Ïµ¿, °æ³² °í¼º±º ¿µ¿À¸é, ÃæºÏ û¿ø±º ¿À¼ÛÀ¾, ÀüºÏ ÀÍ»ê½Ã ¿©»ê¸é, °æ³² ÇԾȱº Ä¥ºÏ¸é, Ãæ³² ´çÁø½Ã ä¿îµ¿, ¼¼Á¾ ÇѼֵ¿, °æ±â ¾È¼º½Ã »ç°îµ¿, ºÎ»ê ¼­±¸ ¼­´ë½Åµ¿1°¡, ºÎ»ê Áß±¸ ³²Æ÷µ¿2°¡, ºÎ»ê Áß±¸ º¸¼öµ¿1°¡, ÀüºÏ ±èÁ¦½Ã º¹Á×µ¿, ºÎ»ê °­¼­±¸ °­µ¿µ¿, ÀüºÏ ÀüÁֽà ¿Ï»ê±¸ È¿ÀÚµ¿3°¡, Ãæ³² °øÁֽà ¿ù¹Ìµ¿, °æ±â ¾È¾ç½Ã ¸¸¾È±¸ ¾È¾ç9µ¿, °æ±â ±ºÆ÷½Ã »êº»µ¿, ºÎ»ê »çÇϱ¸ ½ÅÆòµ¿, Àü³² ¿©¼ö½Ã µ¹»êÀ¾, °æºÏ ¿µÃµ½Ã ±ÝÈ£À¾, ¿ï»ê ºÏ±¸ È¿¹®µ¿, ÀÎõ ³²µ¿±¸ ¼­Ã¢µ¿, ÃæºÏ ¿µµ¿±º ¸Å°î¸é, ¼¼Á¾ ¹Ý°îµ¿, ¿ï»ê ³²±¸ ¼º¾Ïµ¿, µî ´Ù¾çÇÑ Áö¿ª Áֹε鲲¼­ ³»¿øÇÏ°í °è½Ê´Ï´Ù ¼Ûµµ°©»ó¼±ÇÑÀÇ¿øÄ¡·á ãÀ¸½Ã´Â °è¾ç±¸, ±¸¿ùµ¿, ÆÈź¸é, ÀÎõ, µ¿Ãᵿ, ¹è°ð½Åµµ½Ã, µµÈ­µ¿, ºñºÀ¸é, û¶ó, »óµ¿, ¿¬Èñµ¿, Á־ȵ¿, °è»êµ¿, ¸¶µµ¸é, °¡Á¤µ¿, ³²¾çÀ¾, µ¿±¸, µ¿ÀÎõ, ¼Ûµµ, ¼Ûµµ½Åµµ½Ã, ¼Û¿ùµ¿, µµ¸²µ¿, ½ÃÈï, ¹è°ð, °ü±³µ¿, ûÇе¿, ¼Û»ê¸é, ¿î¼­µ¿, ½ÃÈ­, °£¼®µ¿, ¿µÁ¾Çϴõµ½Ã, °¡Áµ¿, ´ëºÎµµ, ÀÎõ³íÇöµ¿, ¼Ò·¡Æ÷±¸ µî ¼Ûµµ Áö¿ª Áֹε鲲¼­ ¹Ì¿ÃÇÑÀÇ¿ø¼ÛµµÁ¡À» ¹æ¹®ÇÏ°í °è½Ê´Ï´Ù. ´õ »ìÆ캸±â 1. CATZ B, RUSSELL S. Myxedema, shock and coma. Seven survival cases. Arch Intern Med 1961; 108:407. 2. Sawka AM, Gerstein HC, Marriott MJ, et al. Does a combination regimen of thyroxine (T4) and 3,5,3'-triiodothyronine improve depressive symptoms better than T4 alone in patients with hypothyroidism? Results of a double-blind, randomized, controlled trial. J Clin Endocrinol Metab 2003; 88:4551. 3. Saravanan P, Simmons DJ, Greenwood R, et al. Partial substitution of thyroxine (T4) with tri-iodothyronine in patients on T4 replacement therapy: results of a large community-based randomized controlled trial. J Clin Endocrinol Metab 2005; 90:805. 4. Aronson R, Offman HJ, Joffe RT, Naylor CD. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch Gen Psychiatry 1996; 53:842. 5. Duntas LH. Selenium and the thyroid: a close-knit connection. J Clin Endocrinol Metab 2010; 95:5180. 6. Pollock MA, Sturrock A, Marshall K, et al. Thyroxine treatment in patients with symptoms of hypothyroidism but thyroid function tests within the reference range: randomised double blind placebo controlled crossover trial. BMJ 2001; 323:891. 7. Hennemann G, Docter R, Visser TJ, et al. Thyroxine plus low-dose, slow-release triiodothyronine replacement in hypothyroidism: proof of principle. Thyroid 2004; 14:271. 8. Blakesley V, Awni W, Locke C, et al. Are bioequivalence studies of levothyroxine sodium formulations in euthyroid volunteers reliable? Thyroid 2004; 14:191.
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ÀÎõ°©»ó¼±ÇÑÀÇ¿ø ÇÑÀÇ¿ø ¼­µÎ¸£¼¼¿ä""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ±Û¾²±â ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ½ÃÈïÇÑÀÇ¿øÀßÇϴ°÷ Ä¡·á Ãʱ⿡ ÀâÀÚ
´ÙÀ½±Û ¼Ûµµ´ÙÀ̾îÆ® ÇÑÀÇ¿ø¿¡¼­
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
832 [¶óÀ²ÇÑÀÇ¿ø] 4¿ùÀ̺¥Æ®, º½À̴ϱî À̺¥Æ®ÇØ º½ 0 1,207 2021-04-01
831 ÆDZ³ ÇüÁÖÇÑÀÇ¿ø ´ÙÀ̾îÆ® È®ÂðÀÚ Å»Ãâ À̺¥Æ® 0 1,997 2021-03-26
830 º½¸ÂÀÌ ´ÙÀ̾îÆ®, ÇǺΰü¸® ÇÔ²²ÇØ¿ä~ (feat: ¼ö¸°ÇÑÀÇ¿ø ¿ÀÇÂÀ̺¥Æ®) 0 1,273 2021-03-26
829 º»ÇÑÀÇ¿ø °³¿ø À̺¥Æ® 0 1,839 2021-03-16
828 ÀϸÆÇÑÀÇ¿ø ºÎ»êÁ¡ ¸ö¸Å¼Òȯ 3¿ù À̺¥Æ® ¹× °¡°Ý 0 1,752 2021-03-16
827 ¿¬ÇÑÀÇ¿ø ù¹ø° À̺¥Æ® ½ÃÀÛÇÕ´Ï´Ù 0 1,724 2021-03-16
826 »ý±âÇÑÀÇ¿ø ½Åµµ¸²Á¡ ·¹Æ®·Î 7080 GOGO 0 1,412 2021-03-16
825 °­³²´ÙÀ̾îÆ®ÇÑÀÇ¿ø ¼±ÀÌ°íÀºÇÑÀÇ¿ø À̺¥Æ® 1 2,917 2021-03-16
824 Àá½Çµ¿ ¸¶À½¸ð¾Æ ÇÑÀÇ¿ø ¿ÀDZâ³ä ¼±¹° / À̺¥Æ® 0 1,170 2021-03-11
823 ±Ô¸²ÇÑÀÇ¿ø õ¾ÈÁ¡ 3¿ù¿¡´Â ÀÌ·± ÇýÅÃÀÌ 0 1,273 2021-03-08
822 À§·ÊÇϴþÖÇÑÀÇ¿ø °³¿ø 3ÁÖ³â ÃÖ´ëÇÒÀÎÀ̺¥Æ® 0 1,178 2021-03-08
821 ¸®¿ÂÇÑÀÇ¿ø 3¿ù À̺¥Æ® ¾çº¼ ÈäÅÍÄ¡·á 3ȸ Ư°¡ 0 1,614 2021-03-02
820 ²ÉÇÇ´Â 3¿ù! ¸®»ù º½ À̺¥Æ® 0 1,543 2021-02-27
819 ¶óÀ²ÇÑÀÇ¿ø ¼³·¹ÀÌ´Â 3¿ù º½¸ÂÀÌ À̺¥Æ® 0 1,667 2021-02-27
818 ÇÏÀ²ÇÑÀÇ¿ø 3¿ù ¾ÆÄí¾ÆÇÊ À̺¥Æ® ¾È³»µå¸³´Ï´Ù 0 1,268 2021-02-24
817 2021 »õÇظÂÀÌ À̺¥Æ®! ´ëÀü Á×µ¿ ¿Ã¹Ù¸¥ÇÑÀÇ¿ø 0 1,117 2021-02-08
816 ¼ö¿ø À̼ÒÇÑÀÇ¿ø ¼³ ¸ÂÀÌ ÇÒÀÎ À̺¥Æ® ¹× Áø·á¾È³» 0 1,083 2021-02-08
815 Âü´ÙÀÎÇÑÀÇ¿ø ¼³ ¿¬ÈÞ Áø·á ¾È³» & À̺¥Æ® 0 1,073 2021-02-08
814 °­µ¿±¸ ÂüÇÑÀÇ¿ø 2¿ù ÇÒÀÎ À̺¥Æ® ¾È³» 0 873 2021-02-08
813 È­°î¿ª ÇÑÀÇ¿ø ¸¼Àº½£365ÇÑÀÇ¿ø °¡º¸¼¼¿ä 3 1,001 2021-02-04
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷